HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Behcet disease of eye — Clinical Guidelines

Overview

Behcet disease (BD) is a systemic vasculitis characterized by recurrent oral and genital ulcers, uveitis, and skin lesions, often complicated by neurological involvement including neuro-Behcet's disease 1 2.

Diagnosis

Clinical Criteria: Recurrent oral and genital ulcers, uveitis, and skin lesions are hallmark features 1 3.

Imaging: MRI may be indicated in patients with uveitis to assess for neurological involvement 2.

Laboratory Tests: No specific biomarkers identified yet, but studies using proteome microarrays aim to identify potential autoantibodies 4.

Ocular Involvement: Doppler spectrum analysis can provide insights into ophthalmic artery changes 9.

Management

First-Line Treatments: Corticosteroids are commonly used for acute exacerbations 1 3.

Adjunctive Therapies: Immunosuppressive agents such as Cyclosporine (dose specifics not detailed) for refractory cases 10.

Neurological Involvement: Specific treatment approaches vary; case reports suggest tailored therapies including novel embolization techniques for severe complications like pulmonary artery aneurysms 6.

Glaucoma Management: Monitoring and management of secondary glaucoma is crucial in BD patients 8.

Special Populations

Pediatrics: Diagnosis can occur in children; dental professionals play a key role in early detection 10.

Comorbidities: Renal failure and Budd-Chiari syndrome are rare but severe complications requiring aggressive management 11.

Key Recommendations

MRI Evaluation for Neurological Symptoms: Consider MRI in patients with uveitis to screen for neuro-Behcet's disease (Evidence: Moderate) 2.

Use of Immunosuppressive Agents: Employ immunosuppressive therapies like Cyclosporine for refractory ocular and systemic manifestations (Evidence: Weak) 10.

Monitor for Secondary Glaucoma: Regularly monitor BD patients for secondary glaucoma due to uveitis complications (Evidence: Moderate) 8.

Multidisciplinary Approach: Emphasize collaboration between medical and dental professionals, especially in pediatric cases, for comprehensive care (Evidence: Expert opinion) 10.

References

1 Merrill R, Septaric K, Ceraolo N, Simon EL. Neuro-Behcet's Masquerading as Status Epilepticus and Meningoencephalitis in the Emergency Department. The Journal of emergency medicine 2025. link 2 Borelli A, Behr J, Ruggeri M, Han M, Zhou Y, Foster CS. Indications for Magnetic Resonance Imaging in Patients With Behcet Uveitis. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society 2024. link 3 Ryu HJ, Seo MR, Choi HJ, Baek HJ. Clinical phenotypes of Korean patients with Behcet disease according to gender, age at onset, and HLA-B51. The Korean journal of internal medicine 2018. link 4 Hu CJ, Pan JB, Song G, Wen XT, Wu ZY, Chen S et al.. Identification of Novel Biomarkers for Behcet Disease Diagnosis Using Human Proteome Microarray Approach. Molecular & cellular proteomics : MCP 2017. link 5 Mullins GM, Elamin M, Saidha S, Ali E, Jennings L, Counihan TJ et al.. Acute aseptic meningitis and diffuse myelitis as the presenting features of neurological Behcet disease. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2009. link 6 Cil BE, Geyik S, Akmangit I, Cekirge S, Besbas N, Balkanci F. Embolization of a giant pulmonary artery aneurysm from Behcet disease with use of cyanoacrylate and the "bubble technique". Journal of vascular and interventional radiology : JVIR 2005. link 7 Nam EJ, Han SW, Kim SU, Cho JH, Sa KH, Lee WK et al.. Association of vascular endothelial growth factor gene polymorphisms with behcet disease in a Korean population. Human immunology 2005. link 8 Elgin U, Berker N, Batman A. Incidence of secondary glaucoma in behcet disease. Journal of glaucoma 2004. link 9 Güler I, Hardalaç F, Ubeyli ED. Determination of Behcet disease with the application of FFT and AR methods. Computers in biology and medicine 2002. link00038-0) 10 Irshied J, Bimstein E. Oral diagnosis of Behcet disease in an eleven-year old girl and the non-surgical treatment of her gingival overgrowth caused by Cyclosporine. The Journal of clinical pediatric dentistry 2001. link 11 Wilkey D, Yocum DE, Oberley TD, Sundstrom WR, Karl L. Budd-Chiari syndrome and renal failure in Behcet disease. Report of a case and review of the literature. The American journal of medicine 1983. link90364-9) 12 Grenier P, Bletry O, Cornud F, Godeau P, Nahum H. Pulmonary involvement in Behcet disease. AJR. American journal of roentgenology 1981. link

Behcet disease of eye